Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?
Izzedine
Hassane
H
Thibault
Vincent
V
Valantin
Marc Antoine
MA
Peytavin
Gilles
G
Schneider
Luminita
L
Benhamou
Yves
Y
D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005198:Fanconi Syndrome / Q000517:prevention & control*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D011339:Probenecid / Q000008:administration & dosage* / Q000009:adverse effects; D055502:Secondary Prevention; D000068698:Tenofovir
D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine; D011339:Probenecid